Deepa Jewellers, Cotec Healthcare obtain Sebi approval for IPOs
Hyderabad-based Deepa Jewellers plans to boost funds by a mixture of recent challenge and offer-for-sale.
The IPO consists of a recent challenge of shares price as much as Rs 250 crore and a proposal on the market of as much as 1.18 crore shares by promoters Ashish Agarwal and Seema Agarwal.
The corporate had filed its draft papers with Sebi in December 2025.
Integrated in 2016, Deepa Jewellers operates as a business-to-business processor and provider of hallmarked gold jewelry with a robust presence in southern India together with Telangana, Karnataka, Andhra Pradesh, Tamil Nadu and Kerala.
The corporate primarily focuses on processing 22-karat gold jewelry and operates by an outsourced manufacturing mannequin supported by round 40 karigars.
Its product portfolio consists of conventional South Indian jewelry classes equivalent to vaddanam, CNC machine-cut bangles, gents kada, vanki, kangan, earrings, mangtika, maatil, braid ornaments and rings.Aside from jewelry processing, the corporate additionally undertakes job-work assignments the place clients provide uncooked materials and the corporate delivers completed ornaments.
Deepa Jewellers can also be engaged in buying and selling silver ornaments, gold bullion, valuable stones and 18-20 karat jewelry merchandise.
Based on the corporate, it had a buyer base of 315 shoppers throughout 13 states and one union territory as of November 2025, together with jewelry retail chains and standalone jewelry shops.
The corporate’s enterprise mannequin is targeted largely on wholesale distribution and processing reasonably than direct retail operations.
Individually, Cotec Healthcare additionally acquired Sebi approval for its IPO.
Cotec Healthcare operates as a contract growth and manufacturing organisation, or CDMOserving pharmaceutical firms throughout a number of therapeutic segments.
The corporate manufactures formulations throughout 24 dosage classes together with injectables, tablets, capsules, ointments, syrups and infusions.
Its product portfolio spans therapeutic areas equivalent to anaesthetics, antibiotics, cardiovascular medicine, dermatology, endocrinology, vitamin, dietary supplements and girls’s healthcare.
Cotec Healthcare operates a producing facility in Roorkee unfold throughout 21,871 sq. metres with put in manufacturing capability of over 4 billion items.
The corporate serves home pharmaceutical firms and in addition exports merchandise to 14 nations.
Based on the corporate’s disclosures, it served 154 clients in FY25 in contrast with 177 in FY24 and 122 in FY23.
